Phlow Corp. is a U.S.-based, public benefit corporation that develops and domestically manufactures APIs and finished pharmaceutical products that are critical to the nation’s healthcare.
External link for Phlow
424 Hull St
Suite 400
Richmond, Virginia 23224, US
Phlow reposted this
Catch up with our latest episode featuring Eric Edwards, MD, PhD, Co-Founder and CEO at Phlow. Don’t forget to subscribe and leave a rating wherever you get your podcast fix… 🎧Apple: https://lnkd.in/eG2pkJyF 🎧Amazon: https://lnkd.in/eFeuwd9Q 🎧Spotify: https://lnkd.in/ehcDmTni #Innovation #Pharmaceuticals #ArtificialIntelligence
Molecule to Market's latest episode, released this morning, features our CEO and Co-Founder, Eric Edwards, MD, PhD. In this interview with Raman Sehgal, Eric discusses his life journey from battling severe allergies to creating groundbreaking medical devices and addressing drug shortages. This story is about resilience, innovation, and dedication to making a difference in healthcare. Tune in to your favorite listening platform to hear Eric's story: 🎧Apple: https://lnkd.in/eG2pkJyF 🎧Spotify: https://lnkd.in/egUcN6rp To read more, click here: https://lnkd.in/eJrd6ynb
Today, our Business Development team members are in the San Francisco Bay Area, attending the regional PBSS International (Pharmaceutical & BioScience Society) conference "CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts, and Best Practices."
Today, our Executive Vice President of Manufacturing, Science, and Technology, Andrew J. Carpenter, Ph.D., will be participating in a panel presentation titled "Enabling Reliability through Advanced Manufacturing Technologies" at the ReVAMPing the Pharmaceutical Supply Chain event hosted by the Duke-Margolis Institute for Health Policy. The panelists for this presentation include Mark Godfrey from Eli Lilly and Company, Gerren McHam from API Innovation Center, and Joel Welch from the U.S. Food and Drug Administration (FDA). The panel will be moderated by Gerrit Hamre from the Duke-Margolis Institute for Health Policy. The group plans to discuss how existing federal programs can drive increased adoption of advanced manufacturing technologies and opportunities for leveraging these technologies for improvements in reliability, quality assurance, and national health security. This hybrid public meeting will be held from 1-5 pm. To register for the event, please click the following link: https://lnkd.in/e6MR9rsb
Phlow reposted this
This Friday, we have an inspiring story from Eric Edwards, MD, PhD, Co-Founder and CEO at Phlow. Eric shares his incredible journey from battling severe allergies to creating groundbreaking medical devices and addressing drug shortages. This story is about resilience, innovation, and dedication to making a difference in healthcare. Find out more and be the first to listen: Spotify 👉 https://ow.ly/I5ET50PlzP0 Apple 👉 https://ow.ly/8kNF50PlzOZ Amazon 👉 https://ow.ly/M3WI50PlzP1 #SupplyChain #Pharmaceuticals #Innovation
Pharma Manufacturing's latest article, "Virginia is for Pharma Lovers," highlights the growing pharma ecosystem in the Richmond-Petersburg Region, fueled by a focused mission — improving access to quality medicines. "Richmond was a city in need of a new identity — and it has found one in the pharma space. Today, the Richmond-Petersburg region, through its collaborative ecosystem and focus on advanced technology, is rebuilding itself as a global hub for pharma manufacturing." writes Karen Langhauser. Phlow is thrilled to be a foundational catalyst to the growth of the region's pharma ecosystem in partnership with the United States Government and members of the Alliance for Building Better Medicine as we work together to re-shore our pharmaceutical industrial base right here at home. Click to read: https://lnkd.in/e53ePz9u
We are incredibly excited to start off this week at the BIO 2024 conference in beautiful San Diego. Phlow's cdmoX team will meet with companies from across the globe to discuss their critical need for U.S.-based drug development and manufacturing through a domestic CDMO that specializes in advanced and innovative approaches for small molecule APIs. We invite you to click to set up a meeting or visit Booth #4556 to explore opportunities to accelerate your product development and manufacturing capabilities. https://lnkd.in/eCd2ZgFh #CDMO #BIO2024 #Conference
Our CEO & Co-founder, Eric Edwards, MD, PhD, was featured in today's article from Pharma Manufacturing. This two-part series details the transformative efforts underway to re-shore drug manufacturing, the progress toward U.S. pharmaceutical sovereignty, the importance of ongoing government support, and the role of advanced technologies such as continuous-flow processes and other green chemistry approaches. Use the link below for part one of Pharma Manufacturing's critically important feature story, by Karen Langhauser, on the status of America's medicine cabinet. https://lnkd.in/gK_4UM3Z #supplychain #reshoring #MadeInAmerica
On this #MemorialDay, we pause to reflect on the profound sacrifices made by the heroes who served our nation. Today, we honor and remember the U.S. Military personnel who paid the ultimate sacrifice and express our deepest gratitude for their service. Let us never forget their courage and commitment to a cause greater than oneself. #MemorialDay #NeverForget
Today, we celebrate four years since Phlow announced that it would act boldly and swiftly to protect America’s medicine cabinet. Since then, our team has embarked on an unwavering mission to ensure a future where every American has access to the essential medicines necessary to sustain life and conquer disease. Thanks to the support of the United States Government through the U.S. Department of Health and Human Services (HHS) Administration for Strategic Preparedness and Response (ASPR), Phlow is helping to create domestic supply chain resiliency and reliability for our country’s most vital medicines. Although we have achieved a great deal in just four years, there is still much work to be done to prevent drug shortages and secure America’s pharmaceutical sovereignty. As a modern medicine manufacturer, we are committed to pushing beyond the boundaries of the status quo. Watch the video to learn more: https://lnkd.in/eQTzZqNQ #SupplyChainResiliency #EssentialMedicines #DrugShortages #BCorp HHS Administration for Strategic Preparedness and Response